Alison Allen | Director, Global Pharmacovigilance (PV) Quality Assurance
Alnylam Pharmaceuticals

Alison Allen, Director, Global Pharmacovigilance (PV) Quality Assurance, Alnylam Pharmaceuticals

Alison currently leads the PV QA team at Alnylam pharmaceuticals ensuring quality oversight of Alnylam’s global post-marketing and PV system which has recently included QA responsibilities for non-interventional studies. She has over 20 years of pharmaceutical industry experience in roles within PV operations, Medical Information, IT and Quality.  She holds an MSc in Quality Management in Scientific Research & Development from Cranfield University.

Appearances:



World Drug Safety Congress EU - Day 2 @ 14:25

04 Quality Assurance Panel – Enhancing cross-departmental collaboration for non-interventional studies

last published: 29/Apr/24 09:27 GMT

back to speakers

Get Involved At World Drug Safety Congress
 

Conference Production


George Mullens
george.mullens@terrapinn.com  
+44 20 8164 3940 

 

Sponsorship & Exhibition Sales


Rohit Dhap
rohit.dhap@terrapinn.com   
+44 20 8164 3001

 

Marketing Opportunities


Karen Duncan
karen.duncan@terrapinn.com